Penelope Gray

Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials

Filipe Colaço Mariz, Penelope Gray, Noemi Bender et al. · The Lancet Infectious Diseases · 2021 · 58 citations

Vaccination, Vaccine Safety, Vaccinology +12

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial

Matti Lehtinen, Camilla Lagheden, Tapio Luostarinen et al. · BMJ Open · 2021 · 44 citations · Full text

Evaluation of HPV type‐replacement in unvaccinated and vaccinated adolescent females—<i>Post‐hoc</i> analysis of a community‐randomized clinical trial (II)

Penelope Gray, Johanna Palmroth, Tapio Luostarinen et al. · International Journal of Cancer · 2018 · 39 citations · Full text

Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts

Ville N. Pimenoff, Penelope Gray, Karolina Louvanto et al. · Cell Host & Microbe · 2023 · 32 citations · Full text

Occurrence of human papillomavirus (HPV) type replacement by sexual risk‐taking behaviour group: Post‐hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)

Penelope Gray, Tapio Luostarinen, Simopekka Vänskä et al. · International Journal of Cancer · 2019 · 27 citations